Clinical Trials Logo
  1. Home
  2. Lung Neoplasm
  3. NCT02965300

The Value of VOCs Analysis in Exhaled Breath for Pulmonary Benign and Malignant Lesion Diagnosis — VOCs  

Lung Neoplasm Clinical Trial

Official title:
The Value of VOCs Analysis in Exhaled Breath for Pulmonary Benign and Malignant Lesion Diagnosis

Clinical Trial Summary

The purpose of this study is to analysis the volatile organic gases(VOCs) in exhaled breath of pulmonary lesion patients and healthy controls, in order to find the difference of composition and concentration among groups.

Clinical Trial Description

Collect the exhaled gas in pulmonary lesion patients and healthy controls, using proton transfer reaction mass spectrometry to analysis the different composition and concentration of VOCs, to find the biomarker gases of distinguishing benign and malignant lesion of lung among different groups， and try to build a diagnostic model for lung lesion. ;

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02965300
Study type Observational
Source Chinese PLA General Hospital
Contact Liang—an Chen, MD,PHD
Phone 8610-55499027
Email cla301@126.com
Status Recruiting
Phase N/A
Start date October 2016
Completion date August 2017
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT05078918 - Comprehensive Care Program for Their Return to Normal Life Among Lung Cancer Survivors N/A
Completed NCT04508270 - Significance of Early Mobilization After VATS-L
Active, not recruiting NCT03667716 - COM701 (an Inhibitor of PVRIG) in Subjects With Advanced Solid Tumors. Phase 1
Completed NCT05469425 - Home-based Preoperative Exercise Training for Lung Cancer Patients Undergoing Surgery N/A
Recruiting NCT05046067 - Feasibility Study of Anatomical Modeling for Image Guided Thoracic Surgery N/A
Terminated NCT03090880 - Prophylaxis of Venous Thromboembolism in Advanced Lung Cancer (PROVE) Phase 3
Recruiting NCT05596760 - Promoting Goals-of-Care Discussions for Patients With Memory Problems and Their Caregivers N/A
Completed NCT02498860 - Efficacy and Safety of Adjuvant Pemetrexed Plus Cisplatin for Adenocarcinoma of Lung Phase 2
Completed NCT02952261 - Application of 3D Printing Technique in Small Pulmonary Nodule Localization N/A
Not yet recruiting NCT06024538 - Role of Cancer-associated Fibroblast, MDSCs and Immune Cell Interplays in the Resistance of Non-small Cell Lung Cancer to Anti-PD1/PD-L1 Therapies
Completed NCT02616211 - An Integrated Approach to Treating Recurrent Thoracic Carcinomas Resistant to Tyrosine Kinase Inhibitors
Recruiting NCT00765986 - Pilot Study of 18F-FAZA in Assessing Early Functional Response in Patients With Inoperable Non Small Cell Lung Cancer Undergoing Radiotherapy or Chemo-radiotherapy N/A
Completed NCT03320044 - Early Diagnosis of Small Pulmonary Nodules by Multi-omics Sequencing
Recruiting NCT03655015 - Patient-derived Organoid Model and Circulating Tumor Cells for Treatment Response of Lung Cancer
Completed NCT03741868 - Symptom Burden and Unmet Supportive Care Needs in Lung Cancer Patients Undergoing First or Second Line Immunotherapy
Completed NCT03749512 - NLCR in Prediction of the Grade of Lung Tumor.
Recruiting NCT03664843 - Circulating Tumor DNA Longitudinal Monitoring in Stage III-IV Lung Cancer Patients
Completed NCT01261507 - Reader Study of DeltaView™ Chest Radiograph Software N/A
Terminated NCT01064050 - Role of a Silicone Prosthesis to Prevent Airway Obstruction Recurrence in Lung Cancers Phase 4
Recruiting NCT03765775 - Anlotinib Plus Sintilimab for NSCLC Patients With First-generation EGFR-TKIs Drug Resistance Along With T790M Negative Phase 2